A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach
Clinical trial NCT02943603 · WITHDRAWN
Trial details
- NCT number
- NCT02943603
- Sponsor
- Weijing Sun, MD, FACP
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2019-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.